Inpatient Care Providers

Pharmacists’ Role to Expand to Direct Patient Care by 2030

January 25, 2022 - Despite growing provider shortages, pharmacists in the US are well-trusted by patients and projected to play an increasingly crucial role in healthcare management, according to research from Columbia University Mailman School of Public Health and Express Scripts Pharmacy. The Prescription of Trust report, the largest study of its kind ever...

Read More


More Articles

UPMC Expands Access to Monoclonal COVID-19 Antibody Treatments

by Samantha McGrail

The University of Pittsburgh Medical Center (UPMC) recently announced expanded access to its potential COVID-19 antibody treatments in outpatient and inpatient settings for eligible...

51% of Retail Pharmacy Customers Used Wellness Services in 2020-21

by Samantha McGrail

Over half of retail pharmacy customers (51 percent)  have used health and wellness services over the past year, according to the J.D. Powers 2021 US Pharmacy Study.  This number is up from...

Abbott Launches Artificial Intelligence-Powered Imaging Platform

by Samantha McGrail

Abbott recently announced that its artificial intelligence-powered,coronary imaging platform launched in Europe.  The platform, which is now CE marked in Europe, is the first-of-its-kind imaging...

AstraZeneca Eyes Medical Devices for Chronic Disease Management

by Samantha McGrail

AstraZeneca and Massachusetts General Hospital (MGH) recently entered into a collaboration to create digital health solutions for chronic disease management.  The collaboration will leverage...

How to Establish an Antibiotic Stewardship Program

by Samantha McGrail

Nearly one in three antibiotic prescriptions written by doctors’ offices, emergency rooms, and hospital-based clinics are inappropriately prescribed annually. But effective and sustainable...

COVID-19 Hospitalizations Spark Overuse of Antibiotic Concerns

by Samantha McGrail

A recent Pew Charitable Trusts study found that over half (52 percent) of COVID-19 hospitalizations during the first six months of the pandemic included antibiotic...

COVID-19 Drug Discovery for Early Treatment Lacking, But Needed

by Samantha McGrail

COVID-19 drug discovery efforts for early treatment of the virus in mild to moderate cases of the virus have been lacking even though successes now could mitigate the impact future outbreaks have on...

Overcoming the Challenges of Distributing COVID-19 Antibody Drugs

by Samantha McGrail

Although prepublication news releases for COVID-19 antibody drugs are common, they often leave clinicians uncertain about how to best leverage the treatments, which are usually in short supply,...

FDA Issues Guidance on Patient Access Requests During COVID-19

by Samantha McGrail

FDA recently issued guidance to the Institutional Review Board (IRBs) regarding expanded access requests for COVID-19 investigational drugs, including expanded access for individual patients. For more...

FDA Approves Lilly’s Advanced Lung, Thyroid Cancer Drug

by Samantha McGrail

Eli Lilly and Company recently announced the FDA approved Retevmo (selpercatinib), the a therapy specifically for the treatment of metastatic rearranged during transfection (RET) driven lung and...

Apple Awards $10M to Give Hospitals COVID-19 Testing Kits

by Samantha McGrail

Apple recently announced it awarded $10 million from its Advanced Manufacturing Fund to COPAN Diagnostics to accelerate its supply of COVID-19 supply kits for hospitals across the US. For more...

Prescription Drug Prices Rose 21% as Utilization Remained Steady

by Samantha McGrail

Prescription drug prices continue to increase due to continued growth in medical service costs and a modest uptick in utilization, according to a recent report from the Health Care Cost Institute...

Recent Articles